Refining and improving treatment options in CLL
The Society of Hematologic Oncology (SOHO)
Hagop M. Kantarjian
Ibrutinib in treatment for refractory or relapsed CLL
The financial burden of cancer treatment and how to address it
What makes the British Society for Haematology (BSH) Annual Scientific Meeting unique?